Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIqgeo Regulatory News (IQG)

Share Price Information for Iqgeo (IQG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 467.00
Bid: 462.00
Ask: 472.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.165%)
Open: 467.00
High: 467.00
Low: 467.00
Prev. Close: 467.00
IQG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors' Dealings

22 Jun 2017 10:51

RNS Number : 8776I
Ubisense Group PLC
22 June 2017
 

22 June 2017

 

Ubisense Group Plc

Directors' Dealings

Ubisense Group plc (LSE:UBI, "Company" or "Ubisense") received notification on 21 June 2017 from Kestrel Partners LLP ("Kestrel") that on 21 June 2017 it acquired, on behalf of its discretionary clients, 115,000 ordinary shares of 2p each ("Shares") in the Company at a price of £0.37 per share. The notification also included the matters set out below.

Kestrel is the investment manager to Kestrel Opportunities, a cell of Guernsey Portfolios PCC Limited ("Kestrel Opportunities"), and various other clients. This disclosure relates to indirect Shares and voting rights in the Company that are managed by Kestrel on a discretionary basis.

Mr Scott is a partner of, and holds a beneficial interest in Kestrel. Mr Scott is also a shareholder in Kestrel Opportunities and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in Ubisense.

Prior to this purchase of Shares, Kestrel on a combined basis indirectly held Shares and voting rights over 15,915,493 Shares in the Company.

Of the Shares purchased, 97,750 were acquired on behalf of Kestrel Opportunities and following this transaction, Kestrel Opportunities holds (and consequently Mr Scott is deemed to have a beneficial interest in) 11,855,785 Shares in the Company. The remaining 17,250 Shares were purchased on behalf of Kestrel's other discretionary clients, in which Mr Scott has no beneficial interest, who, following this transaction, hold a further 4,174,708 Shares in the Company.

Following this transaction and on a combined basis, Kestrel indirectly holds voting rights over 16,030,493 Shares in the Company, which represents approximately 28.69% per cent of the Company's issued share capital.

Kestrel's interest in the Shares in the Company is held through the following nominees:

 

Holding type

Nominee

No. of shares

% of issued share capital

Indirect

Bank of New York Nominees Ltd

11,855,785

21.22%

Indirect

JIM Nominees Limited

1,306,095

2.34%

Indirect

Bank of New York Nominees Ltd

2,868,613

5.13%

 

For further information contact:

 

Ubisense Group PLCPeter Harverson

Tim Gingell

 

+44 (0) 1223 535 170

Numis Securities LimitedSimon Willis

Jamie Lillywhite

Toby Adcock

+44 (0) 20 7260 1000

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHKMGZVLZGGNZG
Date   Source Headline
8th Nov 20167:00 amRNSDirectors' Dealings
27th Oct 20164:18 pmRNSDirectors' Dealings
14th Sep 20167:00 amRNSDirector/PDMR Shareholding
16th Aug 20167:00 amRNSInterim Results
10th Aug 20167:00 amRNSAppointment of CFO
1st Jul 20167:00 amRNSTotal Voting Rights
22nd Jun 201611:02 amRNSResult of AGM
27th May 20167:00 amRNSNotice of AGM
18th May 20167:00 amRNSDirector resignation & appointment
28th Apr 201611:28 amRNSHolding(s) in Company
27th Apr 20162:58 pmRNSHolding(s) in Company
26th Apr 20165:48 pmRNSHolding(s) in Company
26th Apr 20168:00 amRNSDirector's Dealing
25th Apr 20163:18 pmRNSResult of General Meeting
7th Apr 201610:40 amRNS£4.8 million placing
7th Apr 201610:33 amRNSFinal Results
17th Mar 20167:00 amRNSNotice of Results
17th Mar 20167:00 amRNSNew contracts
9th Feb 20167:00 amRNSHolding(s) in Company
25th Jan 20167:00 amRNSTrading Statement
4th Jan 20167:00 amRNSBlocklisting Interim Review
4th Jan 20167:00 amRNSTotal Voting Rights
2nd Dec 20159:20 amRNSDirector/PDMR Shareholding
2nd Dec 20157:00 amRNSHolding(s) in Company
2nd Dec 20157:00 amRNSHolding(s) in Company
1st Dec 20157:00 amRNSTotal Voting Rights
27th Nov 20157:00 amRNSHolding(s) in Company
27th Nov 20157:00 amRNSHolding(s) in Company
23rd Nov 20157:00 amRNSHolding(s) in Company
12th Nov 20157:00 amRNSTrading Update
2nd Nov 20157:00 amRNSTotal Voting Rights
2nd Oct 20157:00 amRNSTotal Voting Rights
16th Sep 20157:00 amRNSHolding(s) in Company
2nd Sep 201511:45 amRNSTotal Voting Rights
1st Sep 20157:04 amRNSHolding(s) in Company
17th Aug 20157:00 amRNSInterim Results
8th Jul 20157:00 amRNSHolding(s) in Company
3rd Jul 20157:00 amRNSTrading Update
1st Jul 20157:00 amRNSBlocklisting Interim Review
30th Jun 20157:00 amRNSTotal Voting Rights
29th Jun 20157:00 amRNSDirectorate Change
5th Jun 20157:00 amRNSTR-1: Notifications of Major Interests in Shares
4th Jun 20157:00 amRNSTR-1: Notifications of Major Interests in Shares
4th Jun 20157:00 amRNSTR-1: Notifications of Major Interests in Shares
4th Jun 20157:00 amRNSUbisense agrees £8 million Revolving Loan Facility
3rd Jun 20157:00 amRNSTR-1: Notifications of Major Interests in Shares
3rd Jun 20157:00 amRNSTR-1: Notifications of Major Interests in Shares
29th May 201510:23 amRNSResult of General Meeting
8th May 20154:34 pmRNSShare Placing
30th Apr 20154:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.